News Column

HARRIS & HARRIS GROUP INC /NY/ FILES (8-K) Disclosing Other Events, Financial Statements and Exhibits

August 4, 2014

Item 8.01. Other Events.

On August 4, 2014, Harris & Harris Group, Inc. (the "Company") announced that its portfolio company, Enumeral Biomedical Corp., completed a reverse merger of the company into a publicly traded shell company simultaneous with the close of a $21.55 million equity round of financing. The surviving entity will be called Enumeral Biomedical Holdings, Inc. ("Enumeral") (formerly known as Cerulean Group, Inc.), and be traded on the OTC Market under the symbol "ENUM." The Company invested $1.5 million in this round of financing, and following this transaction, it will own approximately 15 percent of the outstanding securities of publicly traded Enumeral. The Company's press release is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(a) Not applicable. (b) Not applicable. (c) Not applicable. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated August 4, 2014

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters